Does ENALAPRIL Cause Interstitial lung disease? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Interstitial lung disease have been filed in association with ENALAPRIL (Enalapril maleate oral solution). This represents 0.5% of all adverse event reports for ENALAPRIL.
41
Reports of Interstitial lung disease with ENALAPRIL
0.5%
of all ENALAPRIL reports
16
Deaths
17
Hospitalizations
How Dangerous Is Interstitial lung disease From ENALAPRIL?
Of the 41 reports, 16 (39.0%) resulted in death, 17 (41.5%) required hospitalization, and 13 (31.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENALAPRIL. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does ENALAPRIL Cause?
Acute kidney injury (916)
Drug ineffective (599)
Hypotension (556)
Dyspnoea (514)
Hypertension (451)
Hyperkalaemia (448)
Drug interaction (441)
Angioedema (412)
Off label use (347)
Diarrhoea (342)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ENALAPRIL Alternatives Have Lower Interstitial lung disease Risk?
ENALAPRIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
ENALAPRIL vs ENALAPRIL\LERCANIDIPINE
ENALAPRIL vs ENASIDENIB
ENALAPRIL vs ENBREL
ENALAPRIL vs ENCORAFENIB